Arzneimittelbewertung

Ruxolitinib for patients with polycythemia vera who have had an inadequate response or are intolerant to hydroxyurea: a critical appraisal

Giovanni Barosi

• Abstrakt

Rückblick: Ergebnisse klinischer Studien

Implementation of strategic management tools improves wound care clinical trial outcomes

Marina Malikova, Lauren Shifflett & Alik Farber

• Abstrakt

Arzneimittelbewertung

Nintedanib: a new treatment for idiopathic pulmonary fibrosis

Vincent Cottin

• Abstrakt

Rückblick: Ergebnisse klinischer Studien

Rechallenge with imatinib in advanced gastrointestinal stromal tumors: clinical implications of the RIGHT trial

Changhoon Yoo & Yoon-Koo Kang

• Abstrakt

Arzneimittelbewertung

Linaclotide for irritable bowel syndrome with constipation: a review

Michael Arriaga & Eamonn MM Quigley

• Abstrakt